Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:57 AM
NCT ID:
NCT01613118
Pre Assignment Details:
For the Double-Blind (DB) period, patients were screened to confirm eligibility and underwent 2-wk washout period to discontinue ARBs or ACEIs if necessary. Subjects who completed DB period were evaluated to determine eligibility for the Open-Label Extension (OLE) period (up to 496 additional weeks), those treated with irbesartan were offered sparsentan in the OLE period. Dose changes were permitted during the OLE so all subjects enrolled in OLE are included in RE-021(Sparsentan)-OLE Period arm.
Study:
NCT01613118
Study Brief:
Results Section:
NCT01613118